Mediolanum Raises Nike Stake 434%; Q2 Revenue Tops Estimates by $240M, Dividend Up 2.5%

NKENKE

Mediolanum International Funds boosted its NIKE stake 434.4% to 307,370 shares worth $21.38 million in Q3. Nike reported revenue of $12.43 billion and EPS of $0.53 for the quarter ended December 18, topping consensus by $240 million and $0.16, and increased its dividend 2.5% to $0.41.

1. Institutional Stake Movements in NIKE Inc

In the third quarter, Mediolanum International Funds Ltd increased its NIKE shareholding by 434.4%, acquiring 249,851 additional shares to reach a total of 307,370 shares valued at $21.38 million at quarter-end. Meanwhile, Truist Financial Corp trimmed its position by 5.4%, selling 20,453 shares and holding 356,632 shares worth $24.87 million. Other notable institutional adjustments include Norges Bank’s new $835 million stake in the second quarter and DZ BANK AG’s 3,129.9% increase to 9,091,426 shares valued at $645.86 million.

2. Q3 Earnings and Profitability Metrics

For the quarter ended December 18, NIKE reported revenue of $12.43 billion, surpassing the $12.19 billion consensus by 1.97%, and delivered earnings per share of $0.53 against analyst expectations of $0.37. Return on equity reached 18.43% and net margin stood at 5.43%, while year-over-year revenues grew by 0.6%. Research analysts project full-year EPS of 2.05.

3. Dividend Hike and Payout Profile

The board declared a quarterly dividend of $0.41 per share, up from $0.40, representing an annualized distribution of $1.64 and a yield of 2.7%. The dividend payout ratio rose to 96.47% on trailing earnings, with the ex-dividend date set on December 1 and payment to shareholders of record on that date.

4. Insider Acquisitions and Analyst Revisions

Director Timothy D. Cook purchased 50,000 shares at an average cost of $58.97 for a total of $2.95 million, increasing his stake by 90.12%. CEO Elliott Hill acquired 16,388 shares at $61.10 each, investing $1.00 million and raising his holding by 7.28%. On the research front, Argus cut its target from $85 to $70, KeyCorp lowered its target from $90 to $75 while maintaining an overweight rating, and JPMorgan Chase reduced its target from $100 to $86 with a buy rating; the consensus price objective now stands near $74.61.

Sources

DDD